Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis.

CNS drugs 2024 Vol.38(3) p. 205-224

Shkodina AD, Bardhan M, Chopra H, Anyagwa OE, Pinchuk VA, Hryn KV, Kryvchun AM, Boiko DI, Suresh V, Verma A, Delva MY

관련 도메인

Abstract

Multiple sclerosis is a chronic inflammatory disease that affects the central nervous system and can cause various types of pain including ongoing extremity pain, Lhermitte's phenomenon, trigeminal neuralgia, and mixed pain. Neuropathic pain is a major concern for individuals with multiple sclerosis as it is directly linked to myelin damage in the central nervous system and the management of neuropathic pain in multiple sclerosis is challenging as the options available have limited efficacy and can cause unpleasant side effects. The literature search was conducted across two databases, PubMed, and Google Scholar. Eligible studies included clinical trials, observational studies, meta-analyses, systematic reviews, and narrative reviews. The objective of this article is to provide an overview of literature on pharmacological and non-pharmacological strategies employed in the management of neuropathic pain in multiple sclerosis. Pharmacological options include cannabinoids, muscle relaxants (tizanidine, baclofen, dantrolene), anticonvulsants (benzodiazepines, gabapentin, phenytoin, carbamazepine, lamotrigine), antidepressants (duloxetine, venlafaxine, tricyclic antidepressants), opioids (naltrexone), and botulinum toxin variants, which have evidence from various clinical trials. Non-pharmacological approaches for trigeminal neuralgia may include neurosurgical methods. Non-invasive methods, physical therapy, and psychotherapy (cognitive behavioral therapy, acceptance and commitment therapy and mindfulness-based stress reduction) may be recommended for patients with neuropathic pain in multiple sclerosis. The choice of treatment depends on the severity and type of pain as well as other factors, such as patient preferences and comorbidities. There is a pressing need for healthcare professionals and researchers to prioritize the development of better strategies for managing multiple sclerosis-induced neuropathic pain.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 central nervous system scispacy 1
해부 trigeminal scispacy 1
해부 myelin scispacy 1
해부 muscle relaxants scispacy 1
약물 tizanidine C0146011
tizanidine
scispacy 1
약물 baclofen C0004609
baclofen
scispacy 1
약물 dantrolene C0010976
dantrolene
scispacy 1
약물 benzodiazepines C0005064
Benzodiazepines
scispacy 1
약물 gabapentin C0060926
gabapentin
scispacy 1
약물 phenytoin C0031507
phenytoin
scispacy 1
약물 carbamazepine C0006949
carbamazepine
scispacy 1
약물 lamotrigine C0064636
lamotrigine
scispacy 1
약물 antidepressants C0003289
Antidepressive Agents
scispacy 1
약물 duloxetine C0245561
duloxetine
scispacy 1
약물 venlafaxine C0078569
venlafaxine
scispacy 1
약물 naltrexone C0027360
naltrexone
scispacy 1
약물 opioids scispacy 1
질환 Neuropathic Pain C0027796
Neuralgia
scispacy 1
질환 Multiple sclerosis C0026769
Multiple Sclerosis
scispacy 1
질환 chronic inflammatory disease C1290886
Chronic inflammatory disorder
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 Lhermitte scispacy 1
질환 trigeminal neuralgia C0040997
Trigeminal Neuralgia
scispacy 1
질환 myelin damage scispacy 1
질환 multiple sclerosis-induced neuropathic pain scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1

MeSH Terms

Humans; Multiple Sclerosis; Trigeminal Neuralgia; Acceptance and Commitment Therapy; Neuralgia; Antidepressive Agents; Anticonvulsants

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문